For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Seres Therapeutics Inc (NASDAQ: MCRB) closed at $0.55 down -7.16% from its previous closing price of $0.59. In other words, the price has decreased by -$7.16 from its previous closing price. On the day, 3.47 million shares were traded. MCRB stock price reached its highest trading level at $0.5961 during the session, while it also had its lowest trading level at $0.5495.
Ratios:
For a deeper understanding of Seres Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 3.91 whereas as Long-Term Debt/Eq ratio is at 3.56.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 28 ’24 when von Moltke Lisa sold 4,334 shares for $0.69 per share. The transaction valued at 2,991 led to the insider holds 30,423 shares of the business.
Henn Matthew R. sold 3,984 shares of MCRB for $2,749 on Oct 28 ’24. The insider now owns 75,885 shares after completing the transaction at $0.69 per share. On Oct 28 ’24, another insider, DesRosier Thomas, who serves as the Chief Legal Officer and EVP of the company, sold 4,259 shares for $0.69 each. As a result, the insider received 2,939 and left with 133,414 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 93854680 and an Enterprise Value of 101020296. For the stock, the TTM Price-to-Sale (P/S) ratio is 1452.16 while its Price-to-Book (P/B) ratio in mrq is 3.91. Its current Enterprise Value per Revenue stands at 0.8 whereas that against EBITDA is -2.768.
Stock Price History:
Over the past 52 weeks, MCRB has reached a high of $2.05, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -35.34%, while the 200-Day Moving Average is calculated to be -39.51%.
Shares Statistics:
For the past three months, MCRB has traded an average of 3.60M shares per day and 2551590 over the past ten days. A total of 135.04M shares are outstanding, with a floating share count of 124.68M. Insiders hold about 26.98% of the company’s shares, while institutions hold 23.57% stake in the company. Shares short for MCRB as of 1730332800 were 17852612 with a Short Ratio of 4.96, compared to 1727654400 on 18656453. Therefore, it implies a Short% of Shares Outstanding of 17852612 and a Short% of Float of 14.050001000000002.
